# Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care

> **NCT00783302** · — · COMPLETED · sponsor: **GE Healthcare** · enrollment: 885 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00783302
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-10
- **Final completion:** 2011-04
- **Target enrollment:** 885 (ACTUAL)
- **Last updated:** 2014-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783302, "Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00783302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*